What is IDEXX Laboratories Inc (IDXX)?
IDEXX Laboratories Inc trades as IDXX on the US exchange (US) and is classified under Healthcare in the Closelooknet research universe, as of the registry build of 2026-11-06.
Is IDXX in a Closelooknet index?
Yes — IDEXX Laboratories Inc is a constituent of HALO Growth 100, as of 2026-11-06.
What is IDEXX Laboratories Inc's Closelooknet composite score?
58 out of 100, with momentum 65, quality 85 and valuation 17 sub-scores, as of 2026-11-06. Scores are Closelooknet's own research readings, not ratings or investment advice.
What is the current Closelooknet signal-board read on IDXX?
Down 4% at the close — one of the day's sharpest drops. As of 2026-11-05; the signal board re-bakes nightly. A structure reading from Closelooknet's research diary, not advice.
Where does IDXX trade against its moving averages?
IDEXX Laboratories Inc trades 28.9% above its 50-day and 22.1% above its 200-day moving average (22.9% above its 20-day). As of 2026-11-04 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.
How is IDXX doing against its Closelooknet index?
Over the past month IDEXX Laboratories Inc is +32.4% against +0.4% for the HALO Growth 100 — 32.0 points ahead of its index, as of 2026-11-05. Its Surgical, Med Devices & Animal Health sleeve is +16.9% over the same month. The “Versus its index” table on this page carries the day, the week and the month for the name, its sleeve and the index.
How does IDEXX Laboratories Inc compare with its peers?
Against its peer group (HALO Growth 100 · Surgical, Med Devices & Animal Health), IDEXX Laboratories Inc (IDXX) sits 9.3% below its 52-week high, 28.9% above its 50-day average; DexCom Inc (DXCM) is 4.4% below, Globus Medical (GMED) is 14.1% below, Sonova H Ag (SOON.SW) is at its high, as of 2026-11-04. Put any of them next to IDXX in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.
How does IDEXX Laboratories Inc trade when bond yields rise?
Over the past year IDEXX Laboratories Inc had a beta of 0.83 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 75% of US names. On the 10 sessions in which long bonds fell most it moved −1.32% on average, against −0.74% for the S&P 500. As of 2026-11-05; The "How it trades on rate days" block on this page carries the lines.
What does IDEXX Laboratories Inc do?
IDEXX makes diagnostic instruments and test kits for veterinary clinics, covering blood, urine and companion-animal disease screening. It also sells water-testing kits that detect bacteria such as E. coli, and diagnostic tools for livestock, poultry and dairy operations. Vets and labs buy its analysers, software and consumables as recurring supplies rather than one-off purchases. Closelooknet's peer group places it with Intuitive Surgical, Stryker, DexCom, Insulet, Globus Medical, Sonova and Sartorius, names chosen for similar regulated moats in surgery, sensors and animal health; the market also names Zoetis as a comparable animal-health company. (Company snapshot of 2026-09-17.)
Where does IDEXX Laboratories Inc sit in the AI build-out?
IDEXX carries no seat in our Rubin index, so it sits instead in the HALO Growth 100, our growth index outside the megacaps, within the Surgical, Med Devices & Animal Health sleeve — a group built around regulated, multi-decade compounders in surgical and diagnostic equipment. IDEXX sits in the HALO Growth 100 and the Nasdaq-100. It carries a Closelooknet score, with quality its strongest module and momentum its weakest. (Company snapshot of 2026-09-17.)
Does IDEXX Laboratories Inc pay a dividend?
No cash distribution shows in IDEXX Laboratories Inc’s price series over the last three years. In fiscal 2025 the company bought back 1.22 bn USD of its own shares, 116% of that year’s free cash flow. The share count fell 2.9% over the fiscal year. As of 2026-11-05; the "Dividends and capital return" block on this page carries the lines.
What has Wall Street done on IDEXX Laboratories Inc recently?
The most recent analyst action on IDEXX Laboratories Inc on the Closelooknet wire is a price target by UBS on 2026-11-03 (target 700). 2 actions on the analyst wire since 2026-08-13: 2 target changes. Its latest earnings print on the wire, 2026-11-02: EPS 3.96 against 3.73 expected — a +6.2% beat. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.
What does this page show?
A live price chart with SMA overlays and drawing tools for IDXX, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.